Cargando…

A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab

A 76-year-old man was admitted to our hospital with cough and dyspnea. He was diagnosed with advanced lung cancer. Nivolumab was given as second-line treatment, cytotoxic chemotherapy was given as third-line treatment, and nivolumab re-challenge was given as fourth-line treatment. Thereafter, 41 che...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Keima, Oguri, Tetsuya, Takeda, Norihisa, Fukumitsu, Kensuke, Fukuda, Satoshi, Kanemitsu, Yoshihiro, Tajiri, Tomoko, Ohkubo, Hirotsugu, Takemura, Masaya, Maeno, Ken, Ito, Yutaka, Niimi, Akio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926357/
https://www.ncbi.nlm.nih.gov/pubmed/31890556
http://dx.doi.org/10.1016/j.rmcr.2019.100979
_version_ 1783482080065224704
author Ito, Keima
Oguri, Tetsuya
Takeda, Norihisa
Fukumitsu, Kensuke
Fukuda, Satoshi
Kanemitsu, Yoshihiro
Tajiri, Tomoko
Ohkubo, Hirotsugu
Takemura, Masaya
Maeno, Ken
Ito, Yutaka
Niimi, Akio
author_facet Ito, Keima
Oguri, Tetsuya
Takeda, Norihisa
Fukumitsu, Kensuke
Fukuda, Satoshi
Kanemitsu, Yoshihiro
Tajiri, Tomoko
Ohkubo, Hirotsugu
Takemura, Masaya
Maeno, Ken
Ito, Yutaka
Niimi, Akio
author_sort Ito, Keima
collection PubMed
description A 76-year-old man was admitted to our hospital with cough and dyspnea. He was diagnosed with advanced lung cancer. Nivolumab was given as second-line treatment, cytotoxic chemotherapy was given as third-line treatment, and nivolumab re-challenge was given as fourth-line treatment. Thereafter, 41 chemotherapy courses were administered over 2 years. Currently, he is being followed with no recurrence at least 10 months after treatment. Thus, the case of a patient with advanced lung cancer who was previously unsuccessfully treated with nivolumab and then demonstrated a long-term clinical response to a re-challenge with nivolumab after cytotoxic chemotherapy and radiation therapy is presented.
format Online
Article
Text
id pubmed-6926357
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69263572019-12-30 A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab Ito, Keima Oguri, Tetsuya Takeda, Norihisa Fukumitsu, Kensuke Fukuda, Satoshi Kanemitsu, Yoshihiro Tajiri, Tomoko Ohkubo, Hirotsugu Takemura, Masaya Maeno, Ken Ito, Yutaka Niimi, Akio Respir Med Case Rep Case Report A 76-year-old man was admitted to our hospital with cough and dyspnea. He was diagnosed with advanced lung cancer. Nivolumab was given as second-line treatment, cytotoxic chemotherapy was given as third-line treatment, and nivolumab re-challenge was given as fourth-line treatment. Thereafter, 41 chemotherapy courses were administered over 2 years. Currently, he is being followed with no recurrence at least 10 months after treatment. Thus, the case of a patient with advanced lung cancer who was previously unsuccessfully treated with nivolumab and then demonstrated a long-term clinical response to a re-challenge with nivolumab after cytotoxic chemotherapy and radiation therapy is presented. Elsevier 2019-12-10 /pmc/articles/PMC6926357/ /pubmed/31890556 http://dx.doi.org/10.1016/j.rmcr.2019.100979 Text en © 2019 The Authors. Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Ito, Keima
Oguri, Tetsuya
Takeda, Norihisa
Fukumitsu, Kensuke
Fukuda, Satoshi
Kanemitsu, Yoshihiro
Tajiri, Tomoko
Ohkubo, Hirotsugu
Takemura, Masaya
Maeno, Ken
Ito, Yutaka
Niimi, Akio
A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab
title A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab
title_full A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab
title_fullStr A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab
title_full_unstemmed A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab
title_short A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab
title_sort case of non-small cell lung cancer with long-term response after re-challenge with nivolumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926357/
https://www.ncbi.nlm.nih.gov/pubmed/31890556
http://dx.doi.org/10.1016/j.rmcr.2019.100979
work_keys_str_mv AT itokeima acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT oguritetsuya acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT takedanorihisa acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT fukumitsukensuke acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT fukudasatoshi acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT kanemitsuyoshihiro acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT tajiritomoko acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT ohkubohirotsugu acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT takemuramasaya acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT maenoken acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT itoyutaka acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT niimiakio acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT itokeima caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT oguritetsuya caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT takedanorihisa caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT fukumitsukensuke caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT fukudasatoshi caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT kanemitsuyoshihiro caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT tajiritomoko caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT ohkubohirotsugu caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT takemuramasaya caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT maenoken caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT itoyutaka caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab
AT niimiakio caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab